Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1660
| Despition | GDF7 Mouse Recombinant |
| SIZE | 2 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1608 | Human INHBC Protein (AC1608) | 2 µg | inquiry |
| ACPP-1523 | RPE65 Blocking Peptide (AC1523) | 250 µg | inquiry |
| ACPP-1257 | MC4 Receptor Blocking Peptide (AC1257) | 250 µg | inquiry |
| ACPP-1102 | Recombinant Human Eph Receptor A3 Protein (Fc Chimera 6xHis Tag) (AC1102) | 50 µg | inquiry |
| ACPP-1631 | Human IMPDH1 Protein (AC1631) | 2 µg | inquiry |
| ACPP-1185 | Mouse FGF 1 Protein (AC1185) | 10 µg | inquiry |
| ACPP-1191 | Nogo Blocking Peptide (AC1191) | 250 µg | inquiry |
| ACPP-1698 | Rat GDNF Protein (AC1698) | 2 µg | inquiry |
| ACPP-1614 | Human MPPED2 Protein (AC1614) | 2 µg | inquiry |
| ACPP-1774 | Human CRKL Protein (AC1774) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.